Rounds Report: Solid Rallied While FDA Due Diligence To Help Branded Therapeutic Innovators
Rounds Report: Solid Rallied While FDA Due Diligence To Help Branded Therapeutic Innovators.....»»
Rounds Report: Eiger Rallied While Sesen Bio Posted The Strong Interim Data For VISTA
Rounds Report: Eiger Rallied While Sesen Bio Posted The Strong Interim Data For VISTA.....»»
Rounds Report: Crispr Rallied While The FDA Approved Lumivascular
Rounds Report: Crispr Rallied While The FDA Approved Lumivascular.....»»
Rounds Report: Melinta Rallied While The FDA Approved OsteoDetect
Rounds Report: Melinta Rallied While The FDA Approved OsteoDetect.....»»
Rounds Report: Madrigal Rallied, While Iterum Experienced Significant Insider Purchases
Rounds Report: Madrigal Rallied, While Iterum Experienced Significant Insider Purchases.....»»
Rounds Report: Nektar Rallied Aggressively While Lexicon Experienced Significant Insider Purchases
Rounds Report: Nektar Rallied Aggressively While Lexicon Experienced Significant Insider Purchases.....»»
Rounds Report: Melinta Rallied While Novavax Experienced Significant Insider Purchases
Rounds Report: Melinta Rallied While Novavax Experienced Significant Insider Purchases.....»»
Rounds Report: TransEnterix Moved North, FDA Due Diligence To Benefit Nektar
Rounds Report: TransEnterix Moved North, FDA Due Diligence To Benefit Nektar.....»»
Rounds Report: Versartis Rallied Due To Strong Turnaround Progress
Rounds Report: Versartis Rallied Due To Strong Turnaround Progress.....»»
Rounds Report: Solid Biosciences Made Big Waves While The FDA Approved Eversense
Rounds Report: Solid Biosciences Made Big Waves While The FDA Approved Eversense.....»»
Rounds Report: Axovant Rallied While The FDA Approved Epidiolex
Rounds Report: Axovant Rallied While The FDA Approved Epidiolex.....»»
Rounds Report: Adamis Rallied Due To A Commercialization Partnership
Rounds Report: Adamis Rallied Due To A Commercialization Partnership.....»»
Rounds Report: Endocyte Rallied While The Tricida IPO Was A Success
Rounds Report: Endocyte Rallied While The Tricida IPO Was A Success.....»»
Rounds Report: Galmed Rallied Subsequent To The Overweight Rating Of Dr. Elemer Piros
Rounds Report: Galmed Rallied Subsequent To The Overweight Rating Of Dr. Elemer Piros.....»»
Rounds Report: Aveo Rallied As Investors Are Optimistic About TIVO-3 Future Development
Rounds Report: Aveo Rallied As Investors Are Optimistic About TIVO-3 Future Development.....»»
Rounds Report: AVEO Rallied As Investors Are Optimistic About TIVO-3 Future Development
Rounds Report: AVEO Rallied As Investors Are Optimistic About TIVO-3 Future Development.....»»
Rounds Report: Durect Rallied Due To The FDA Approval Of RBP-7000
Rounds Report: Durect Rallied Due To The FDA Approval Of RBP-7000.....»»
Rounds Report: Progenics Rallied Subsequent To The Azedra Approval
Rounds Report: Progenics Rallied Subsequent To The Azedra Approval.....»»
Will Zillow Beat Estimates Again in Its Next Earnings Report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Zillow Group (NASDAQ: ZG). read more.....»»
Is Amazon Stock Worth Buying Ahead of Q1 Earnings?
Amazon (NASDAQ: AMZN) is scheduled to report first-quarter 2024 results on Apr 30. The company has been rising on its dominant position in the online retail and cloud computing markets. It has been benefiting from the solid momentum across Prime and Am.....»»
Interim report Q1, 2024: Strong growth in APAC and solid margins
GOTHENBURG, Sweden, April 18, .....»»